Pages that link to "Q33832256"

The following pages link to Patients and Methods of the PATH Biobank - A Resource for Breast Cancer Research (Q33832256):

Displaying 9 items.

• Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data (Q28076506) (← links)
• The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up (Q30993896) (← links)
• AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection (Q35432936) (← links)
• AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection (Q36101969) (← links)
• The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer (Q47582689) (← links)
• Biobanking from the patient perspective (Q51101144) (← links)
• Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue (Q57807838) (← links)
• Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells (Q90662131) (← links)
• Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy (Q91894593) (← links)